Documents & Downloads

Brigatinib-d11

Stable Isotope

Brigatinib-d11 is a deuterium-labeled analog of Brigatinib, a highly selective and potent inhibitor of the anaplastic lymphoma kinase (ALK) with an IC50 of 0.6 nM. This stable isotope labeling allows for advanced tracking and analysis in metabolic studies. Brigatinib-d11 is suitable for research applications focused on non-small cell lung cancer (NSCLC) treatment mechanisms and drug metabolism studies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2055306-76-6
Applications	Stable Isotope
Formula	C₂₉H₂₈D₁₁ClN₇O₂P
Molecular Weight	595.16
Synonyms	AP-26113-d11
SMILES	COC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)P(C)(C)=O)=N2)C=CC(N4CCC(N5C([2H])([2H])C([2H])([2H])N(C([2H])([2H])C5([2H])[2H])C([2H])([2H])[2H])CC4)=C1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.